DexCom Inc. (NASDAQ:DXCM) is one of the best growth stocks to buy in 2026. On December 2, Morgan Stanley upgraded DexCom to Overweight from Equal Weight with a price target of $75, which was up from ...
Diabeloop announced today that its DBLG2 algorithm for automated insulin delivery has received FDA 510(k) clearance.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback